Elevated hepatic enzymes (ALT, AST) have consistently been associated with preeclampsia severity and adverse maternal outcomes (29–31), and our findings extend this evidence by demonstrating their predictive value in a multimorbidity cohort where hepatocellular injury and systemic inflammation may converge with metabolic stress from GDM (32). The gene discussed is GPT; the disease is preeclampsia.